학술논문
First-line pembrolizumab (pembro) with or without lenvatinib (lenva) in patients with advanced urothelial carcinoma (LEAP-011): A phase 3, randomized, double-blind study.
Document Type
Journal
Author
Loriot, Yohann; Grivas, Petros; De Wit, Ronald; Balar, Arjun Vasant; Siefker-Radtke, Arlene O.; Zolnierek, Jakub; Csoszi, Tibor; Shin, Sang Joon; Park, Se Hoon; Atduev, Vagif; Gumus, Mahmut; Su, Yu-Li; Karaca, Saziye Burcak; Cutuli, Hernan; Sendur, Mehmet Nahit; Jia, Calvin; O'Hara, Karen; Franco, Sonia; Matsubara, Nobuaki
Source
Subject
Language
English
ISSN
15277755